Yasuo Inoue Selected Research

Yasuo Inoue Research Topics

Disease

13	Rheumatoid Arthritis 11/2017 - 04/2008
3	Neoplasms (Cancer) 10/2005 - 08/2002
2	Dehydration (Water Stress) 01/2015 - 01/2014
2	Neuroblastoma 03/2003 - 08/2002
1	Liver Abscess 06/2022
1	Brain Abscess (Abscess, Brain) 06/2022
1	Dysarthria (Spastic Dysarthria) 06/2022
1	Abscess 06/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 02/2018
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 02/2018
1	Paraparesis 02/2018
1	Edema (Dropsy) 02/2018
1	Brain Stem Infarctions (Weber Syndrome) 01/2016
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 01/2016
1	Ruptured Aneurysm 01/2016
1	False Aneurysm (Pseudoaneurysm) 01/2016
1	Cerebellar Ataxia (Dysmetria) 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2016
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2016
1	Bone Resorption 09/2012
1	Wounds and Injuries (Trauma) 02/2011
1	Infections 02/2011
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2010
1	Ischemia 04/2010
1	Brain Ischemia (Cerebral Ischemia) 04/2010
1	Necrosis 04/2009
1	Bursitis (Adhesive Capsulitis) 01/2009
1	Contracture 01/2009
1	Teratocarcinoma 07/2006
1	Glioma (Gliomas) 10/2005
1	Meningioma (Meningiomas) 10/2005
1	Pheochromocytoma 08/2002

Drug/Important Bio-Agent (IBA)

5	Infliximab (Remicade)FDA Link 01/2015 - 04/2008
4	golimumab FDA Link 11/2017 - 01/2015
4	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2009
3	C-Reactive ProteinIBA 01/2016 - 02/2011
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 04/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 10/2005
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 04/2009
2	Phosphotransferases (Kinase)IBA 01/2016 - 01/2009
2	Mitogen-Activated Protein KinasesIBA 01/2016 - 01/2009
2	limaprostIBA 01/2015 - 01/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 04/2009 - 01/2009
2	Hematoxylin (Haematoxylon)IBA 04/2009 - 01/2009
2	Glycoproteins (Glycoprotein)IBA 07/2006 - 03/2003
2	polysialic acidIBA 03/2003 - 08/2002
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 03/2003 - 08/2002
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2022
1	SteroidsIBA 02/2018
1	Abatacept (Orencia)FDA Link 01/2016
1	CXC ChemokinesIBA 01/2016
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2016
1	MitogensIBA 01/2016
1	Prednisolone (Predate)FDA LinkGeneric 04/2015
1	InterleukinsIBA 01/2015
1	amsonic acid (DAS)IBA 11/2014
1	OsteoprotegerinIBA 09/2012
1	tocilizumab (atlizumab)FDA Link 09/2012
1	Matrix Metalloproteinases (MMPs)IBA 02/2011
1	CalciumIBA 04/2010
1	ManganeseIBA 04/2010
1	titanium dioxide (Titania)FDA Link 04/2010
1	Bromodeoxyuridine (BrdU)IBA 04/2009
1	Etanercept (Enbrel)FDA Link 04/2009
1	NF-kappa B (NF-kB)IBA 01/2009
1	Capsules (Microcapsules)IBA 01/2009
1	FibrinIBA 01/2009
1	Methotrexate (Mexate)FDA LinkGeneric 06/2008
1	AcidsIBA 07/2006
1	Mannose (D-Mannose)IBA 07/2006
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2005
1	von Willebrand FactorIBA 10/2005
1	Glucose (Dextrose)FDA LinkGeneric 10/2005
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 10/2005
1	EpitopesIBA 08/2002
1	AntigensIBA 08/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2002

Therapy/Procedure

3	Synovectomy 04/2015 - 06/2008
2	Aftercare (After-Treatment) 01/2016 - 04/2008
1	Craniotomy 06/2022
1	Conservative Treatment 06/2022
1	Carotid Endarterectomy 01/2022
1	Radiotherapy 01/2016
1	Activities of Daily Living (ADL) 01/2016
1	Intra-Articular Injections 01/2016
1	Subcutaneous Injections 01/2016
1	Joint Capsule Release 04/2015
1	Orthopedic Procedures 02/2011
1	Therapeutics 06/2008
1	Knee Replacement Arthroplasty (Total Knee Replacement) 04/2008